Researchers identify back pain genes
A study led by scientists at King’s College London and the University of Washington, has identified three new genes associated with the development of chronic back pain.
The findings, published in PLOS Genetics, could pave the way for the creation of more effective treatments for the condition which is the leading cause of disability worldwide.
Part funded by the EU, the research project focused on understanding why in most people an episode of back pain gets better, while in around 20% of people it can persist for many months – chronic back pain is defined as pain that persists for more than three months.
To better understand the origins of the chronic condition, researchers conducted a genome-wide association meta-analysis (combined results of multiple chronic back pain studies looking at genetic variants in different individuals) comprising a total of 440,000 individuals. The average age of the study’s participants ranged from 50 to 76 years, and the genders were approximately balanced.
Scientists identified three highly important associations of genes implicated in bone and intervertebral disc development – suggesting that the origins of chronic back pain are associated with degeneration of the spine:
- the strongest genetic association with back pain identified by the researchers was provided by a variant in the SOX5 gene, which is involved in cartilage and bone development and also influences human height. Since human height is contributed to by spine bone and cartilage, this finding is highly plausible
- one of the other genes identified, GSDMC, has also been found by other researchers to be implicated in a form of back and leg pain called sciatica. This also points to spine degeneration as causing back pain
- the third gene, DCC, has been implicated in nerves growing in to the intervertebral disc. This is thought to be the mechanism by which discs, which normally don’t contain nerves so can’t perceive pain, can become painful.
These findings are in keeping with previous epidemiological research conducted by Twins UK at King’s College London, which showed that spine degeneration was one of the strongest predictors for back pain episodes.
Lead researcher Professor Frances Williams, Professor of Genomic Epidemiology at King’s College London, said:
These results are exciting because the genes tell us about disease pathways which are important to chronic back pain. We were expecting to find genes involved in pain pathways, such as in the peripheral nerves or brain, but to our surprise we identified those influencing the skeletal spine structures. By investigating these genes further, we will potentially be able to target new pathways with treatments to slow the aging process in the spine.
The King’s Health Partners Genetics, Rheumatology, Infection, Immunology and Dermatology Clinical Academic Group promotes academic input into the delivery of state-of-the-art clinical services, fuels investigative clinical research, and promotes the translation of basic science discoveries.